RT Book, Section A1 Neuman, Heather B. A1 Van Zee, Kimberly J. A2 Kuerer, Henry M. SR Print(0) ID 6414647 T1 Chapter 63. Axillary Lymph Node Dissection T2 Kuerer's Breast Surgical Oncology YR 2010 FD 2010 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-160178-8 LK accesssurgery.mhmedical.com/content.aspx?aid=6414647 RD 2024/10/09 AB The status of the axillary lymph nodes is the most significant factor predictive of long-term survival in patients with breast cancer. Axillary lymph node dissection (ALND) is an effective staging procedure and provides durable local control with a low rate of recurrence (NSABP B-4).1 Furthermore, although ALND has never been associated with an improvement in overall survival in individual randomized controlled trials (RCT), a meta-analysis of trials comparing ALND with observation suggests that a benefit exists.2